The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.
See why Cognito’s headset received FDA Breakthrough Device Designation for addressing cognitive and functional symptoms associated with Alzheimer’s.
MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.
Researchers found the walls of the brain’s small arteries are also affected in Alzheimer’s, reducing blood flow. Learn about this new treatment target.
Amyloid Scans diagnose and treat Alzheimer’s, at a hefty price. 11 years after FDA approval, Medicare can finally help.
Talk therapy may improve symptoms of depression for people with dementia, providing hope for those who typically do not benefit from antidepressant medication.
Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sample. In other words, this blood test can diagnose Alzheimer’s.
The tendency of Alzheimer’s patients to sleep throughout the day is not due to nighttime insomnia — it has to do with the degeneration of a type of neuron, according to a research study.
Early evidence indicates that ketogenic therapy is a safe and effective treatment for Alzheimer’s Disease and other forms of dementia. Dr. Stephen Cunnane discusses how ketogenic therapies can help.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
INNOVATION – VIDEO: A big supermarket launched a ‘relaxed’ checkout lane to make life a little less stressful for people with dementia and other vulnerable people.
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
